Nigel Theobald discusses the benefits of nanotechnology
N4 Pharma has been featured in the latest issue of BioPharm International.
Catching up in Cambridge
We recently joined a full house of attendees at CrownBio’s annual conference.
An interview with Nigel Theobald
Nigel Theobald, CEO of N4 Pharma, has spoken to Dr. Kevin Robinson at Manufacturing Chemist magazine about how the company has developed Nuvec® and the impact it could have for vaccines and cancer treatments.
N4 Pharma in SHARES Magazine
N4 Pharma has been featured in the latest issue of SHARES Magazine.
N4 Pharma is developing Nuvec®
A unique non-viral adjuvant delivery system for vaccines and cancer treatments.
N4 Pharma’s recent Nuvec® update
Allan Hey, Head of CMC, N4 Pharma Ltd, gave a presentation on Nuvec® at the BioNow Oncology Conference on Wednesday 13th February.
UK Investor Magazine – N4 Pharma: a consumer-driven reformulation and generics specialist
N4 Pharma (LON:N4P) is a consumer-driven pharmaceutical company developing reformulations of a number of key drugs.
N4 Pharma Shares Spotlight
Download the Shares Spotlight pdf
Shares Magazine – Small caps poised for big news in 2018
Investors are spoiled for choice when it comes to small cap stocks with exciting events. As a taster for what’s to come in 2018, we’ve scoured the markets to look for some of the most interesting activities. Read on to discover 19 stocks either expecting big news in the [...]